Owens & Minor Expects 2025 Revenues Of $10.85B-$11.15B And Adjusted EPS Of $1.60-$1.85 Versus Consensus Of $10.97B And $1.79, Respectively

Benzinga
02/28

2025 Financial Outlook

The Company issued its outlook for 2025; summarized below:

  • Revenue for 2025 to be in a range of $10.85 billion to $11.15 billion
  • Adjusted EBITDA for 2025 to be in a range of $560 million to $590 million
  • Adjusted EPS for 2025 to be in a range of $1.60 to $1.85

The Company's outlook for 2025 excludes any impact of the previously announced Rotech acquisition, any potential transaction involving the Products & Healthcare Services segment, or share repurchase activity, and contains assumptions, including current expectations regarding the impact of general economic conditions.

Key assumptions supporting the Company's 2025 financial guidance include:

  • Gross margin of 20.75% to 21.25%
  • Interest expense of $138 million to $142 million
  • Adjusted effective tax rate of 29.0% to 30.0%
  • Diluted weighted average shares of ~80 million
  • Capital expenditures, gross, of $250 million to $270 million
  • Stable commodity prices
  • FX rates as of 12/31/2024

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10